Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Prim Care Companion CNS Disord. 2021 Aug 5;23(4):21br02930. doi: 10.4088/PCC.21br02930.

Kevin Y Xu^{1

2}, Carrie M Mintz¹, Jacob T Borodovsky^{1

3}, Paul E A Glaser⁴, Laura J Bierut^{1

5}, Richard A Grucza^{1

6}

¹ Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.
² Corresponding author: Kevin Y. Xu, MD, MPH, Department of Psychiatry, Washington University School of Medicine, 420 South Euclid Ave, Campus Box 8134, St Louis, MO 63110 (xukeviny@wustl.edu).
³ Center for Technology and Behavioral Health, Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
⁴ William Greenleaf Eliot Division of Child Psychiatry, Washington University School of Medicine, St Louis, Missouri.
⁵ Alvin J Siteman Cancer Center, Barnes Jewish Hospital and Washington University School of Medicine, St Louis, Missouri.
⁶ Departments of Family and Community Medicine and Health and Outcomes Research, St Louis University, St Louis, Missouri.

No abstract available

MeSH terms